Yuya Sugiyama Selected Research

Yuya Sugiyama Research Topics

3	Neoplasms (Cancer) 10/2022 - 01/2020
2	Pathologic Constriction (Stenosis) 03/2022 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 09/2020
2	Ulcerative Colitis 08/2021 - 01/2021
1	Atrial Fibrillation 10/2022
1	Hemorrhage 10/2022
1	Malnutrition (Nutritional Deficiencies) 03/2022
1	Vomiting 03/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	Melanoma (Melanoma, Malignant) 10/2021
1	Gastritis 10/2021
1	Colitis 01/2021
1	Syncope (Fainting) 01/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Adenocarcinoma 09/2020
1	Margins of Excision 09/2020
1	Carcinogenesis 01/2020
1	Esophageal Stenosis (Esophageal Stricture) 01/2019
1	Pneumococcal Infections 01/2013
1	Infections 01/2013
1	Pneumococcal Pneumonia 01/2013
1	Pneumonia (Pneumonitis) 01/2013

2	Immune Checkpoint InhibitorsIBA 01/2022 - 10/2021
1	Heparin (Liquaemin)FDA LinkGeneric 10/2022
1	Warfarin (Coumadin)FDA LinkGeneric 10/2022
1	carbazochrome (Adona)IBA 10/2022
1	NivolumabIBA 01/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 08/2021
1	Biomarkers (Surrogate Marker)IBA 08/2021
1	AntibodiesIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Dextran SulfateIBA 01/2021
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2021
1	SteroidsIBA 01/2019
1	EnzymesIBA 01/2013
1	ImmunosorbentsIBA 01/2013
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2013
1	AntigensIBA 01/2013
1	Imipenem FDA Link 01/2013

4	Therapeutics 01/2022 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
1	Gastrostomy 03/2022
1	Punctures 03/2022
1	Remission Induction 08/2021
1	Blood Component Removal (Apheresis) 08/2021
1	Surgical Instruments (Clip) 09/2020
1	Gastrectomy 09/2020
1	Pancreaticoduodenectomy 01/2020